Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
IL-38 (human) (rec.) (His)
690
CHF
CHF 690.00
In stock
AG-40A-0191-C05050 µgCHF 690.00
Figure 1: NH2-terminal sequence analysis.
| Product Details | |
|---|---|
| Synonyms | Interleukin-38; Interleukin-1 Family Member 10 theta; IL-1F10; FIL1 theta; FKSG75; IL-1HY2; IL1-theta; Interleukin-1 HY2; Interleukin-1 Receptor Antagonist FKSG75 |
| Product Type | Protein |
| Properties | |
| Source/Host | E. coli |
| Sequence |
Human IL-38 (aa 1-152) is fused at the C-terminus to a His-tag. |
| Crossreactivity | Human |
| MW | ~18kDa (SDS-PAGE) |
| Purity | ≥95% (SDS-PAGE) |
| Purity Detail | Purified using Ni-NTA column and FPLC. |
| Endotoxin Content | <1EU/μg purified protein (LAL test; Lonza). |
| Concentration |
After reconstitution: for 10µg size: 0.1mg/ml for 50µg size: 1 mg/ml |
| Reconstitution |
10µg size: Reconstitute with 100µl sterile water. 50µg size: Reconstitute with 50µl sterile water. |
| Formulation | Lyophilized from 0.2μm-filtered solution in 55mM TRIS-Cl, pH 8.2, containing 150mM NaCl. |
| Other Product Data |
UniProt link Q8WWZ1: IL-38 (human) |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. |
| Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. After reconstitution, prepare aliquots and store at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
IL-38 (IL-1F10) mRNA is expressed in heart, placenta, fetal liver, spleen, thymus and tonsil. The expression in a variety of immune tissues and similarity to IL-1Ra suggest a role of IL-1F10 in the inflammatory response. It has been reported that removal of the N-terminus domain of the interleukins of the IL-1F family such as IL-1F5 / 6 / 8 or 9 (also called IL-36Ra, IL-36α, IL-36β or IL-36γ) is important to increase their biological activity. Recently it has been shown that IL-38 is N-terminally processed and secreted by apoptotic cells. Released processed IL-38 (20-152) binds to the receptor Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1; TIGIRR-2) at the surface of macrophages. Processed IL-38-activated IL1RAPL1 reduces the production of IL-6 leading to inflammation attenuation.
Product References
- Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses: J. Mora, et al.; J. Mol. Cell Biol. 8, 426 (2016)
- Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes: D. Talabot-Ayer, et al.; PLoS One 14, e0225782 (2019)
- Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma: X. Sun, et al.; Cell Mol. Immunol. 17, 631 (2020)
- Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy: Y. Pan, et al.; Int. Immunopharmacol. 91, 107300 (2021)
- Multifaceted roles of IL-38 in inflammation and cancer: A. Diaz-Barreiro, et al.; Cytokine 151, 155808 (2022)
- IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation: J.P. Dowling, et al.; MABS 15, 2212673 (2023)
Related Products
